Estimating the cost related to surveillance of colorectal cancer in a French population
Estimating the cost related to surveillance of colorectal cancer in a French population
复制标题
DOI：
10.1007/s10198-009-0144-7
复制
发表时间：
2009-10-01
影响因子：
4.4
通讯作者：
Bonithon-Kopp, Claire
中科院分区：
文献类型：
--
作者：
Lejeune, Catherine;Binquet, Christine;Bonithon-Kopp, Claire
对接受结直肠癌根治性切除的患者的监测费用知之甚少。这项研究的目的是计算385名患者在3年随访中观察到的监测成本，在遵守法国指南的情况下估计监测成本，并确定与监测成本相关的决定因素，以使用线性混合模型得出法国的全球估计。观察到的平均监测成本是a，而不是符号713。如果严格执行法国的建议，根据腹部超声的频率，估计的平均费用将在a而不是符号680和a而不是符号1069之间变化。费用的预测决定因素是：年龄、复发、自诊断以来的监测时间和辅助治疗。对法国来说，监测费用占结直肠癌治疗费用的4.4%。现在，监测的成本应该与其有效性相平衡，并与监测替代方案进行比较。
Little is known about costs related to the surveillance of patients that have undergone curative resection of colorectal cancer. The aim of this study was to calculate the observed surveillance costs for 385 patients followed-up over a 3-year period, to estimate surveillance costs if French guidelines are respected, and to identify the determinants related to surveillance costs to derive a global estimation for France, using a linear mixed model. The observed mean surveillance cost was a,not sign 713. If French recommendations were strictly applied, the estimated mean cost would vary between a,not sign 680 and a,not sign 1,069 according to the frequency of abdominal ultrasound. The predicted determinants of cost were: age, recurrence, duration of surveillance since diagnosis, and adjuvant treatments. For France, the surveillance cost represented 4.4% of the cost of colorectal cancer management. The cost of surveillance should now be balanced with its effectiveness and compared with surveillance alternatives.